Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Diphenyl cresyl phosphate has low toxicity but can harm the liver, kidneys, adrenal glands, and testicles at high doses.

The studies identified key factors and potential treatments for skin and hair disorders.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

The developed system could effectively treat hair loss and promote hair growth.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

A woman with a rare hormone resistance condition also had missing teeth and hair loss, which might be new symptoms of her genetic disorder.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

A boy's hair loss improved after tumor removal and vitamin D treatment, but hair loss returned despite normal vitamin D and no tumor regrowth.

Minoxidil response testing helps treat hair loss effectively and safely.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Rabbit skin with active hair growth shows thicker, redder areas due to larger, more numerous hair follicles and increased blood vessels.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

The hepatitis B vaccine did not cause hair loss in the tested mice.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Genetic testing is crucial for diagnosing congenital atrichia, a rare condition causing irreversible hair loss.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Genetic testing confirmed a rare skin disorder in a young girl, which improved with zinc supplementation.

Preventing cancer involves lifestyle changes, vaccinations, early screening, and understanding cancer's molecular basis.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The ShorT method can detect and help reduce bias in medical AI by identifying shortcut learning.

Dermal papilla microtissues could be useful for initial hair growth drug testing.

Light can turn on hair growth cells through a nerve path starting in the eyes.

Some skin lymphomas can look like common skin issues and need careful testing to diagnose correctly.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Canine hypothyroidism can be linked to diabetes, requiring thorough testing for proper diagnosis.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

About 41% of Indian hair loss patients have low enzyme activity that affects hair loss treatment effectiveness, with men affected more than women. Testing for this can guide treatment.